Trial Details

COMPLETED
Basic Information
Clinical ID c1342
Identifier NCT00096655
Trial Title A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis
Interventions DRUG: Infliximab
Participant Information
Sponsor Centocor, Inc.
City -
Country/Region -
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2025-05-02
Primary Completion Date -
Completion Date 2025-08-07